aMoon — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in
BoardMansoor Mirza(Director)
Co-investorsExcelestar VenturesOUP (Osage University Partners)UpStart VenturesVivo CapitalCatalyst Health VenturesDomain Associates
Scipher Medicine is a precision immunology company that combines molecular data from autoimmune patients, protein interaction mapping, and AI to match patients with the most effective therapy for immunological diseases.
AI & Machine LearningBiotechDigital Health
Joseph Loscalzo(Founder | Physician-in-Chief, Brigham and Women's Hospital)Albert-László Barabási(Founder | Professor, Harvard and Northeastern University)
Co-investorsKhosla VenturesB3 HoldingCobalt VenturesEcho Health VenturesHitachi VenturesOptum Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.